New study examines different approaches for selective internal radiation therapy (SIRT) for advanced liver cancer
This recent phase 2 trial examined the effects of personalised dositometry versus standard dositometry of selective internal radiation therapy (SIRT) for treatment of unresectable locally-advanced hepatocellular carcinoma.
Floorworld and partners step up to support Pancare again this April during Oesophageal Cancer Awareness Month
In November 2020 specialty flooring retailer Floorworld launched an innovative partnership with Pancare that activated the national Floorworld store network, key category suppliers and their customers. The Floorworld community rallied, and they were able to raise an incredible $27,000 for Pancare. Pancare Foundation are thrilled to announce that Floorworld and their supplier partners will once again step up to support Pancare this April.
New study examines different chemotherapy approaches for locally-advanced pancreatic cancer.
This recent well-designed study examined the effects of various chemotherapy regimens for treatment of locally inoperable pancreatic cancer.
Overcoming cancer-related fatigue
Cancer-related fatigue (CRF) is one of the most debilitating and common side effects of cancer and its treatment. Find out how it affects you and how you can cope.
Co-funded research grant for biliary cancer
Together with our peers at the GI Cancer Institute, the Pancare Foundation are pleased to announce a co-funded biliary cancer research grant of up to $100,000 for a new project that will be assessed at the upcoming Australian Gastrointestinal Trials Group (AGIGT) Cholangiocarcinoma Idea Generation Workshop.
Pancare raising awareness at a shopping centre near you
Pancare Foundation is pleased to partner with Adflex Marketing and Loyalty Promotions, raising awareness of pancreatic and other upper gastrointestinal (GI) cancers in communities across Australia.
Pancare Foundation's new website launches
Pancare Foundation is proud to launch a new website featuring the latest, trusted information about upper gastrointestinal (GI) cancers to better support Australians diagnosed and living with pancreatic, liver, stomach, biliary and oesophageal cancers.
Ground-breaking pancreatic cancer research in NSW gets $13 million push
The Cancer Institute of NSW announced yesterday that has awarded $13 million to cancer research, a bulk of which will go toward improving outcomes for people with pancreatic cancer.